background image

Clinical Trials In Austin

Discover hundreds of clinical trials in Austin.
Search clinical trials in Austin by condition or phase.

e.g. Respiratory Diseases
Austin•Healthy volunteers: No

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Recruiting
PHASE2
PHASE3

Sponsor:

AbbVie

Location:

Weslaco, Shavano Park, San Antonio, San Antonioshow 111 more

Code:

NCT06345339

Conditions

Hypothyroidism

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Armour Thyroid

Levothyroxine

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

Recruiting
PHASE3

Sponsor:

Celcuity Inc

Location:

Tyler, Sugar Land, McKinney, Houstonshow 66 more

Code:

NCT05501886

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gedatolisib

Palbociclib

Fulvestrant

Alpelisib

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Recruiting
PHASE1
PHASE2

Sponsor:

OncoResponse, Inc.

Location:

San Antonio, Irving, Austin, Fairfax

Code:

NCT06090266

Conditions

Cancer

Tumor, Solid

Malignant Neoplasm

Metastatic Cancer

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OR502

Cemiplimab

Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention

Recruiting

Sponsor:

Trinity College

Location:

San Marcos, Hartford, Laramie

Code:

NCT04885166

Conditions

Prescription Drug Abuse (Not Dependent)

Intentional Misuse

Eligibility Criteria

Sex: All

Age: 17 - 25

Healthy Volunteers: Not accepted

Interventions

Web-based placebo presentation

Web-based simulation active intervention

Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS

Recruiting
PHASE3

Sponsor:

CSL Behring

Location:

San Antonio, McKinney, Dallas, Austinshow 19 more

Code:

NCT06524739

Conditions

Post-COVID Postural Orthostatic Tachycardia Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IgPro20

Placebo

PAS-004 in Patients With Advanced Solid Tumors

Recruiting
PHASE1

Sponsor:

Pasithea Therapeutics Corp.

Location:

San Antonio, Irving, Austin, Fairfax

Code:

NCT06299839

Conditions

RAS Mutation

NF1 Mutation

RAF Mutation

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PAS-004

A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

Recruiting

Sponsor:

Sumitomo Pharma Switzerland GmbH

Location:

San Antonio, San Antonio, Houston, Houstonshow 59 more

Code:

NCT05467176

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Relugolix

ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

Recruiting
PHASE3

Sponsor:

Stealth BioTherapeutics Inc.

Location:

The Woodlands, San Antonio, Plano, McAllenshow 30 more

Code:

NCT06373731

Conditions

Age Related Macular Degeneration (ARMD)

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Elamipretide

Placebo

Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Recruiting
PHASE1

Sponsor:

Schrödinger, Inc.

Location:

Houston, Austin, Denver, Fairwayshow 8 more

Code:

NCT05961839

Conditions

Acute Myeloid Leukemia

High-Risk and Very High-Risk Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SGR-2921

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease

Recruiting
PHASE2

Sponsor:

Bristol-Myers Squibb

Location:

Round Rock, Houston, Houston, Dallasshow 130 more

Code:

NCT06268886

Conditions

Alzheimer Disease, Early Onset

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

BMS-986446

Placebo